Wikisage, the free encyclopedia of the second generation, is digital heritage

Flibanserin: Difference between revisions

From Wikisage
Jump to navigation Jump to search
(Created page with "fibraserin is a new FDA aproved drug. Former developed in nEurope by Boeringer I latter in US by Sprout Pharmaceutical due it refusal by Health Authory in 2013 <gallery>File:...")
 
 
(9 intermediate revisions by the same user not shown)
Line 1: Line 1:
fibraserin is a new FDA aproved drug.
flibaserin is a new FDA aproved drug, it was formerly developed in Europe by Boeringer Ingelheim latter in US by Sprout Pharmaceutical due it refusal by Health Authority in 2013<ref>http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM215437.pdf</ref>Flibanserin is a post-synaptic 5-hydroxytryptamine (5-HT) 1A receptor agonist and 5-HT 2A antagonist that has been evaluated for indications of major depressive disorder (MDD) and for the
Former developed in nEurope by Boeringer I latter in US by Sprout Pharmaceutical due it refusal by Health Authory in 2013
treatment of [[Hypoactive sexual desire disorder|HSDD]] in premenopausal women.<ref>http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM449088.pdf</ref>
<gallery>File: flibanserina-structural.svg.png</gallery>
<gallery>File:flibanserin-structural.svg.png</gallery>
 
 
==Links==
 
[http://jama.jamanetwork.com/article.aspx?articleid=2389384 Evaluation of Flibanserin Science and Advocacy at the FDA]
 
[http://informahealthcare.com/doi/pdf/10.1517/14656566.2015.1064393 Why are there no FDA-approved treatments for female sexual dysfunction?]
 
{{refs}}

Latest revision as of 01:23, 8 July 2019

flibaserin is a new FDA aproved drug, it was formerly developed in Europe by Boeringer Ingelheim latter in US by Sprout Pharmaceutical due it refusal by Health Authority in 2013[1]Flibanserin is a post-synaptic 5-hydroxytryptamine (5-HT) 1A receptor agonist and 5-HT 2A antagonist that has been evaluated for indications of major depressive disorder (MDD) and for the treatment of HSDD in premenopausal women.[2]


Links

Evaluation of Flibanserin Science and Advocacy at the FDA

Why are there no FDA-approved treatments for female sexual dysfunction?

References

References: